Immuron Ltd (IMRN) stock
IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.88−0.03 (-3.52%)
Close on Nov 13, 2026Market cap $7.06MP/E –Yield –
Immuron gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2026 it was 64.5%, against 65.4% the year before. The highest annual figure on record is 97.8% in fiscal 2018.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | 64.5% | −0.9 |
| FY2025 | Jun 30, 2025 | 65.4% | −2.7 |
| FY2024 | Jun 30, 2024 | 68.1% | −4.5 |
| FY2023 | Jun 30, 2023 | 72.5% | +4.1 |
| FY2022 | Jun 30, 2022 | 68.4% | +3.4 |
| FY2021 | Jun 30, 2021 | 65.0% | −7.7 |
| FY2020 | Jun 30, 2020 | 72.6% | +0.6 |
| FY2019 | Jun 30, 2019 | 72.0% | −25.7 |
| FY2018 | Jun 30, 2018 | 97.8% | +21.9 |
| FY2017 | Jun 30, 2017 | 75.8% | +5.9 |
| FY2016 | Jun 30, 2016 | 69.9% | – |
See a number that looks wrong?